JR14a: A novel antagonist of C3aR attenuates neuroinflammation in cerebral ischemia-reperfusion injury
Open Access
- 27 May 2024
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 213, 110986
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Neuroprotective effect of alpha-kinase 1 knockdown against cerebral ischemia through inhibition of the NF-κB pathway and neuroinflammationInternational Immunopharmacology, 2022
- Sepsis-Associated Encephalopathy and Blood-Brain Barrier DysfunctionInflammation, 2021
- The complement C3‐C3aR pathway mediates microglia–astrocyte interaction following status epilepticusGlia, 2020
- CFLAR is a critical regulator of cerebral ischaemia-reperfusion injury through regulating inflammation and endoplasmic reticulum (ER) stressBiomedicine & Pharmacotherapy, 2019
- The Role of Complement C3a Receptor in StrokeNeuroMolecular Medicine, 2019
- The complement system in ischemia–reperfusion injuriesImmunobiology, 2012
- Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcomeClinical Biochemistry, 2008
- Neutrophils and the blood–brain barrier dysfunction after traumaMedicinal Research Reviews, 2006
- Expression of the complement C3a and C5a receptors after permanent focal ischemia: An alternative interpretationGlia, 2002
- Intra-arterial Prourokinase for Acute Ischemic StrokeJAMA, 1999